News archive

An open collection of tips and tools could help researchers and publishers to pick up on problematic research.

Group behind Retraction Watch aims to pinpoint the most influential flawed health data.

Bot-made art undermines research and public trust in science, say illustrators frustrated by inaccurate and outlandish depictions.

The COVID-19 pandemic showed the value of changing direction in research. It should be incentivized, encouraged and celebrated.

The race is on to build tools that can detect fradulent AI-generated images in research.

Researchers say a lack of funding for studies that focus on sex and gender might also hasten a US brain drain.

Analysis flags hundreds of studies that seem to follow a template, reporting correlations between complex health conditions and single variables based on publicly available data sets.

Collaborations between privately run foundations provide an opportunity to fund risky science that governments cannot take on.

Jakub Pachocki, who leads the firm’s development of advanced models, is excited to release an open version to researchers.

The country’s publication policies should balance the need to promote science locally with the benefits of disseminating research internationally.

New data have revealed a potential slow-down in cancer-research funding growth from major institutions in the United States.

Asian countries continue to climb as European research output stalls. 

Contingency plans are needed to shore up important information.

Unique reproducibility effort in Brazil focuses on common methods rather than a single field ― and prompts call for reform.

Some general journals, including Nature and Science, barely make the top 100, finds a Nature Index analysis of author gender. 

Emerging companies and an evolving market are changing the dynamics of cancer trials.

China takes pole position in cancer-related research in the Nature Index, with a massive jump in output.

These scientists are coming at cancer from all angles.

Cancer blood tests and AI-powered scans look promising for quicker and more accurate detection of disease.

Vaccine scepticism could undermine important progress in cancer research.